We report the dramatic shift of the oncology activity at our department during a 5-week period (9 March–13 April 2020) as compared with the same calendar interval in 2019 . Overall, our Medical Oncology Department has experienced remarkable drop in activity. The number of outpatient’s visits decreased by 23%. One of the most worrisome concern is that the new oncology referrals were reduced by 37%, and the number of patients enrolled in clinical trials decreased by 43%. These data would mean that nearly 4 out 10 patients with cancer have been missed or their treatment delayed.
No takes yet. Share an insight, caveat, or question.
Manso et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: